Evidence map›Paper›PMID 33446410›Full record

GuidelineJournal of the American College of Cardiology2021

2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.

Writing Committee, Thomas M Maddox, James L Januzzi, Larry A Allen, Khadijah Breathett, Javed Butler, Leslie L Davis, Gregg C Fonarow, Nasrien E Ibrahim, JoAnn Lindenfeld and 8 more

2 registry-linked trialsAbstract readConsensus StatementPractice Guideline
PubMed Publisher
In one paragraph

Guideline in Journal of the American College of Cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 382 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
382citing papers in PubMed, 10 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05759000 unknown statusstarted 2023, after this paper: background citation

The Effect of Early Inpatient Initiation of Dapagliflozin on the Health-related Quality of Life of Patients With Heart Failure With All Range of Ejection Fraction: a Local Registry

Ran2023Enrolled100Registered outcomes12Posted comparisons0ConditionsHeart FailureArmsdapagliflozin
Open the trial in the graph
NCT05583513 completednot on this mapstarted 2022, after this paper: background citation

Evaluation of the Progression of Disease and Health-related Quality of Life in Ambulatory Heart Failure Patients: A Local Clinic-based Registry

Typeobservational_patient_registrySponsorChinese University of Hong KongRan2022 to 2023Enrolled500ConditionsHeart FailureArmsMLHFQ (Minnesota Living with Heart Failure Questionnaire), KCCQ (the Kansas City Cardiomyopathy Questionnaire)
3 · Its place in the literature

Who cites it

382 citing papers in PubMed, 10 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Model parameters influencing the cost-effectiveness of sacubitril/valsartan in heart failure: evidence from a systematic literature review.The European journal of health economics : HEPAC : health economics in prevention and care · 2023
    Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Article
  19. Review
  20. Article

322 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Writing Committee
Thomas M Maddox
James L Januzzi
Larry A Allen
Khadijah Breathett
Javed Butler
Leslie L Davis
Gregg C Fonarow
Nasrien E Ibrahim
JoAnn Lindenfeld
Frederick A Masoudi
Shweta R Motiwala
Estefania Oliveros
J Herbert Patterson
Mary Norine Walsh
Alan Wasserman
Clyde W Yancy
Quentin R Youmans

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Disease ManagementStroke VolumeAdvisory CommitteesCardiologyHeart FailureHumansUnited StatesACC Expert Consensus Decision PathwayARNIheart failureHFrEFSGLT2 inhibitor

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.